Rare diseases
Investigational molecules
Locations
Back to Poland1 228 clinical trials in Cracow, Poland across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study of icotrokinra for adults with moderately to severely active Crohn's disease
PolandTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
PolandA study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before
PolandTesting Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia
PolandA Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer
PolandA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
PolandA Study Testing Casdatifan and Cabozantinib Compared to Placebo and Cabozantinib in Patients With Advanced Clear Cell Kidney Cancer
PolandA Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer
PolandA study to evaluate the long-term safety and effectiveness of afimkibart in patients with atopic dermatitis who took part in previous afimkibart studies
PolandA study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation
PolandA Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment
PolandA study comparing injection under the skin versus infusion into the vein of tislelizumab with chemotherapy for patients with advanced gastric or gastroesophageal junction cancer
PolandThe busiest research cities in the country
What the registry says about research in the country
In Kraków, clinical trials in type 2 diabetes, chronic kidney disease, hyperlipidemia, and hypoparathyroidism are exploring new ways to improve long-term disease control and protect organ function.
These studies aim to refine treatment effectiveness and support patients living with chronic metabolic conditions.
A strong group of studies focuses on cardiovascular disease, heart failure, hypertension, atrial fibrillation, and acute myocardial infarction, with the goal of improving prevention and treatment outcomes.
Several trials in the city are also looking at ways to improve recovery after cardiac procedures and lower future cardiovascular risk.
Many trials in Kraków address immune-mediated diseases such as systemic lupus erythematosus, Sjögren’s syndrome, and psoriatic arthritis, with an emphasis on better symptom control and disease suppression.
Research in this area also includes conditions where immune dysfunction affects multiple organs and daily quality of life.
Skin-focused trials cover atopic dermatitis, plaque psoriasis, vitiligo, alopecia areata, and hidradenitis suppurativa, reflecting a broad effort to improve visible and often persistent inflammatory conditions.
These studies aim to offer more effective options for people living with conditions that can strongly affect daily well-being.
Trials in asthma, COPD, chronic rhinosinusitis with nasal polyps, and allergic rhinitis are examining ways to improve breathing, reduce flare-ups, and ease chronic airway inflammation.
Researchers are especially interested in therapies that may lower exacerbation rates and improve everyday respiratory function.
Clinical research in ulcerative colitis, Crohn’s disease, non-alcoholic steatohepatitis, and alcohol-related liver disease is aiming to improve inflammation control and reduce long-term complications.
Some studies also address patients with more complex digestive conditions that need long-term management.
Neurological studies include multiple sclerosis, Alzheimer’s disease, migraine, epilepsy, and narcolepsy, reflecting broad interest in both chronic and progressive brain disorders.
These trials focus on symptom reduction, disease slowing, and better day-to-day functioning for patients with neurological conditions.
Research on breast cancer, non-small cell lung cancer, lymphoma, multiple myeloma, and leukemia is an important part of the trial landscape in Kraków.
These studies seek to improve survival, response rates, and treatment options for both solid tumors and blood-related cancers.
Several trials address genetic and rare diseases such as Marfan syndrome, congenital adrenal hyperplasia, nephrotic syndrome, and other inherited conditions.
These studies are especially valuable for patients with uncommon conditions where treatment choices are limited.
Trials in COVID-19, HIV-1 infection, meningococcal infection, and fungal infections are focused on prevention, treatment, and better disease control.
This area includes both active treatment studies and work aimed at lowering future infection risk.
Studies in juvenile idiopathic arthritis, axial spondyloarthritis, systemic sclerosis, and chronic pain-related disorders are examining ways to reduce inflammation and improve mobility.
Researchers are looking for therapies that can ease stiffness, pain, and movement limitations over time.
Trials involving endometriosis, pregnancy-related conditions, contraception, and menopausal symptoms reflect a broad commitment to women’s health research.
These studies are designed to improve comfort, planning options, and quality of life across different stages of life.
Some trials focus on behavior change, smoking and vaping cessation, and sleep-related problems such as narcolepsy and excessive daytime sleepiness.
These studies combine medical and behavioral approaches to help people improve daily habits and alertness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
